|
1
|
Geerts WH, Heit JA, Claggett GP, et al:
Prevention of venous thromboembolism. Chest. 119(1 Suppl):
132S–175S. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heit JA: The epidemiology of venous
thromboembolism in the community. Arterioscler Thromb Vasc Biol.
28:370–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martinelli I: Risk factors in venous
thromboembolism. Thromb Haemost. 86:395–403. 2001.PubMed/NCBI
|
|
4
|
Clagett GP, Anderson FA Jr, Heit J, Levine
MN and Wheeler HB: Prevention of venous thromboembolism. Chest.
108(4 Suppl): 312S–334S. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kahn SR, Lim W, Dunn AS, et al: American
College of Chest Physicians: Prevention of VTE in nonsurgical
patients: Antithrombotic therapy and prevention of thrombosis, 9th
ed: American College of Chest Physicians evidence-based clinical
practice guidelines. Chest. 141(2 Suppl): e195S–e226S. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shackford SR, Rogers FB, Terrien CM,
Bouchard P, Ratliff J and Zubis R: A 10-year analysis of venous
thromboembolism on the surgical service: the effect of practice
guidelines for prophylaxis. Surgery. 144:3–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smeeth L, Cook C, Thomas S, Hall AJ,
Hubbard R and Vallance P: Risk of deep vein thrombosis and
pulmonary embolism after acute infection in a community setting.
Lancet. 367:1075–1079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiang-Hua Y, Le-Min W, Ai-Bin L, et al:
Severe acute respiratory syndrome and venous thromboembolism in
multiple organs. Am J Respir Crit Care Med. 182:436–437. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong Z, Liang AB, Wang LM, et al: The
expression and significance of immunity associated genes mRNA in
patients with pulmonary embolism. Chin J Intern Med. 48:666–669.
2009.(In Chinese).
|
|
10
|
Wang L, Song H, Gong Z, Duan Q and Liang
A: Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell
immunity. Am J Respir Crit Care Med. 184:13152011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haoming S, Lemin W, Zhu G, et al: T
cell-mediated immune deficiency or compromise in patients with
CTEPH. Am J Respir Crit Care Med. 183:417–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O’Leary JG, Goodarzi M, Drayton DL and von
Andrian UH: T cell- and B cell-independent adaptive immunity
mediated by natural killer cells. Nat Immunol. 7:507–516. 2006.
View Article : Google Scholar
|
|
13
|
Duan Q, Gong Z, Song H, et al: Symptomatic
venous thromboembolism is a disease related to infection and immune
dysfunction. Int J Med Sci. 9:453–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Janeway CA Jr, Travers P, Walport M and
Shlomchik MJ: Immunobiology: The Immune System in Health and
Disease. 5th edition. Garland Science; New York: 2001
|
|
15
|
Gauld SB and Cambier JC: Src-family
kinases in B-cell development and signaling. Oncogene.
23:8001–8006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nitschke L and Tsubata T: Molecular
interactions regulate BCR signal inhibition by CD22 and CD72.
Trends Immunol. 25:543–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yokozeki T, Adler K, Lankar D and Bonnerot
C: B cell receptor-mediated Syk-independent activation of
phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein
kinase pathways. J Immunol. 171:1328–1335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharma S, Orlowski G and Song W: Btk
regulates B cell receptor-mediated antigen processing and
presentation by controlling actin cytoskeleton dynamics in B cells.
J Immunol. 182:329–339. 2009. View Article : Google Scholar
|
|
19
|
Huntington ND, Xu Y, Puthalakath H, et al:
CD45 links the B cell receptor with cell survival and is required
for the persistence of germinal centers. Nat Immunol. 7:190–198.
2006. View
Article : Google Scholar
|
|
20
|
Ohtsuka M, Arase H, Takeuchi A, et al:
NFAM1, an immunoreceptor tyrosine-based activation motif-bearing
molecule that regulates B cell development and signaling. Proc Natl
Acad Sci USA. 101:8126–8131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horikawa K, Nishizumi H, Umemori H, Aizawa
S, Takatsu K and Yamamoto T: Distinctive roles of Fyn and Lyn in
IgD- and IgM-mediated signaling. Int Immunol. 11:1441–1449. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sohn HW, Krueger PD, Davis RS and Pierce
SK: FcRL4 acts as an adaptive to innate molecular switch dampening
BCR signaling and enhancing TLR signaling. Blood. 118:6332–6341.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu M, Granillo O, Wen R, et al: Negative
regulation of lymphocyte activation by the adaptor protein LAX. J
Immunol. 174:5612–5619. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwakkenbos MJ, Pouwels W, Matmati M, et
al: Expression of the largest CD97 and EMR2 isoforms on leukocytes
facilitates a specific interaction with chondroitin sulfate on B
cells. J Leukoc Biol. 77:112–119. 2005.
|
|
25
|
McLellan AD, Starling GC, Williams LA,
Hock BD and Hart DN: Activation of human peripheral blood dendritic
cells induces the CD86 co-stimulatory molecule. Eur J Immunol.
25:2064–2068. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu G, Flies DB, Tamada K, Sun Y,
Rodriguez M, Fu YX and Chen L: Progressive depletion of peripheral
B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha-transgenic mice. J
Immunol. 167:2671–2676. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mak TW, Shahinian A, Yoshinaga SK, et al:
Costimulation through the inducible costimulator ligand is
essential for both T helper and B cell functions in T
cell-dependent B cell responses. Nat Immunol. 4:765–772. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Knobeloch KP, Wright MD, Ochsenbein AF, et
al: Targeted inactivation of the tetraspanin CD37 impairs
T-cell-dependent B-cell response under suboptimal costimulatory
conditions. Mol Cell Biol. 20:5363–5369. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ostberg JR, Dragone LL, Driskell T, et al:
Disregulated expression of CD43 (leukosialin, sialophorin) in the B
cell lineage leads to immunodeficiency. J Immunol. 157:4876–4884.
1996.PubMed/NCBI
|
|
30
|
Tedla N, Gibson K, McNeil HP, Cosman D,
Borges L and Arm JP: The co-expression of activating and inhibitory
leukocyte immunoglobulin-like receptors in rheumatoid synovium. Am
J Pathol. 160:425–431. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Colonna M, Nakajima H, Navarro F and
López-Botet M: A novel family of Ig-like receptors for HLA class I
molecules that modulate function of lymphoid and myeloid cells. J
Leukoc Biol. 66:375–381. 1999.PubMed/NCBI
|
|
32
|
Hanten JA, Vasilakos JP, Riter CL, et al:
Comparison of human B-cell activation by TLR7 and TLR9 agonists.
BMC Immunol. 9:392008. View Article : Google Scholar
|
|
33
|
Józsi M, Prechl J, Bajtay Z and Erdei A:
Complement receptor type 1 (CD35) mediates inhibitory signals in
human B lymphocytes. J Immunol. 168:2782–2788. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cella M, Döhring C, Samaridis J, et al: A
novel inhibitory receptor (ILT3) expressed on monocytes,
macrophages, and dendritic cells involved in antigen processing. J
Exp Med. 185:1743–1751. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fujikawa K, Miletic AV, Alt FW, et al:
Vav1/2/3-null mice define an essential role for Vav family proteins
in lymphocyte development and activation but a differential
requirement in MAPK signaling in T and B cells. J Exp Med.
198:1595–1608. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JK, Mathew SO, Vaidya SV, Kumaresan PR
and Mathew PA: CS1 (CRACC, CD319) induces proliferation and
autocrine cytokine expression on human B lymphocytes. J Immunol.
179:4672–4678. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Defrance T, Carayon P, Billian G, et al:
Interleukin 13 is a B cell stimulating factor. J Exp Med.
179:135–143. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Braun D, Caramalho I and Demengeot J:
IFN-alpha/beta enhances BCR-dependent B cell responses. Int
Immunol. 14:411–419. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abed NS, Chace JH, Fleming AL and Cowdery
JS: Interferon-gamma regulation of B lymphocyte differentiation:
activation of B cells is a prerequisite for IFN-gamma-mediated
inhibition of B cell differentiation. Cell Immunol. 153:356–366.
1994. View Article : Google Scholar : PubMed/NCBI
|
